Literature DB >> 27199178

Health policy: Overcoming cost barriers to clinical trial participation.

Neal J Meropol1.   

Abstract

Mesh：

Year:  2016        PMID： 27199178     DOI： 10.1038/nrclinonc.2016.72

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  9 in total

1.  The imperative to address the cost of oncology care.

Authors:  Neal J Meropol
Journal:  J Natl Cancer Inst       Date:  2013-11-13       Impact factor: 13.506

2.  Patient income level and cancer clinical trial participation.

Authors:  Joseph M Unger; Dawn L Hershman; Kathy S Albain; Carol M Moinpour; Judith A Petersen; Kenda Burg; John J Crowley
Journal:  J Clin Oncol       Date:  2013-01-07       Impact factor: 44.544

3.  Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials.

Authors:  Joseph M Unger; Charles A Coltman; John J Crowley; Laura F Hutchins; Silvana Martino; Robert B Livingston; John S Macdonald; Charles D Blanke; David R Gandara; E David Crawford; Kathy S Albain
Journal:  J Clin Oncol       Date:  2005-12-05       Impact factor: 44.544

4.  Incremental costs of enrolling cancer patients in clinical trials: a population-based study.

Authors:  J L Wagner; S R Alberts; J A Sloan; S Cha; J Killian; M J O'Connell; P Van Grevenhof; J Lindman; C G Chute
Journal:  J Natl Cancer Inst       Date:  1999-05-19       Impact factor: 13.506

5.  Cancer trials versus the real world in the United States.

Authors:  Waddah B Al-Refaie; Selwyn M Vickers; Wei Zhong; Helen Parsons; David Rothenberger; Elizabeth B Habermann
Journal:  Ann Surg       Date:  2011-09       Impact factor: 12.969

6.  Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity Program.

Authors:  Ryan D Nipp; Hang Lee; Elizabeth Powell; Nicole E Birrer; Emily Poles; Daniel Finkelstein; Karen Winkfield; Sanja Percac-Lima; Bruce Chabner; Beverly Moy
Journal:  Oncologist       Date:  2016-03-14

7.  American Society of Clinical Oncology guidance statement: the cost of cancer care.

Authors:  Neal J Meropol; Deborah Schrag; Thomas J Smith; Therese M Mulvey; Robert M Langdon; Diane Blum; Peter A Ubel; Lowell E Schnipper
Journal:  J Clin Oncol       Date:  2009-07-06       Impact factor: 44.544

8.  Financial Concerns About Participation in Clinical Trials Among Patients With Cancer.

Authors:  Yu-Ning Wong; Mark D Schluchter; Terrance L Albrecht; Al Bowen Benson; Joanne Buzaglo; Michael Collins; Anne Lederman Flamm; Linda Fleisher; Michael Katz; Tyler G Kinzy; Tasnuva M Liu; Sharon Manne; Seunghee Margevicius; Dawn M Miller; Suzanne M Miller; David Poole; Stephanie Raivitch; Nancy Roach; Eric Ross; Neal J Meropol
Journal:  J Clin Oncol       Date:  2015-12-23       Impact factor: 44.544

9.  Randomized Trial of a Web-Based Intervention to Address Barriers to Clinical Trials.

Authors:  Neal J Meropol; Yu-Ning Wong; Terrance Albrecht; Sharon Manne; Suzanne M Miller; Anne Lederman Flamm; Al Bowen Benson; Joanne Buzaglo; Michael Collins; Brian Egleston; Linda Fleisher; Michael Katz; Tyler G Kinzy; Tasnuva M Liu; Seunghee Margevicius; Dawn M Miller; David Poole; Nancy Roach; Eric Ross; Mark D Schluchter
Journal:  J Clin Oncol       Date:  2015-12-23       Impact factor: 44.544
  9 in total
  1 in total

1.  Older adults in phase I clinical trials: a comparative analysis of participation and clinical benefit rate among older adults versus middle age and AYA patients on phase I clinical trials with VEGF/VEGFR inhibitors.

Authors:  Ishwaria M Subbiah; Chad Tang; Arvind Rao; Gerald S Falchook; Vivek Subbiah; Apostolia M Tsimberidou; Daniel Karp; Razelle Kurzrock; David S Hong
Journal:  Oncotarget       Date:  2018-06-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.